New classification for identifying HR myeloma based on cytogenetic abnormalities
Dr Alun Passey speaks with ecancer at the HARMONY Project general assembly 2018 in Valencia.
He gives an overview about his role in the project.
To see more from HARMONY visit their website.
New classification for identifying HR myeloma based on cytogenetic abnormalities
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Synthetic biology and precision medicine in blood and gynaecological cancers
OncoAlert Round Up for September 15-21, 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 25th - 31st, 2023
Latest in immunological technologies that can treat, control, and prevent cancer
The use of IORT at Universitätsmedizin Mannheim hospital
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours